SCHEMBL962360

SCHEMBL962360

[CH2]CCCC(Br)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8837345 0.90
SCHEMBL2094998 0.87
SCHEMBL8837296 0.87
SCHEMBL2090578 0.87
SCHEMBL2093086 0.87
SCHEMBL959278 0.77
SCHEMBL4357181 0.76
SCHEMBL2567606 0.76
SCHEMBL96906 0.73
SCHEMBL2566428 0.72 LCK (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240065265-A1 METHODS FOR CONTROL OF PESTS BIO-GENE TECHNOLOGY LIMITED (AU) 2024-02-29 US disclosed
WO-2023245257-A1 IMPROVED PESTICIDAL COMPOSITIONS AND PEST CONTROL METHODS BIO-GENE TECHNOLOGY LIMITED (AU) 2023-12-28 WO disclosed
US-11800866-B2 Methods for control of pests Bio-Gene Technology Unlimited (AU) 2023-10-31 US disclosed
US-20230292751-A1 CONTROL OF RESISTANT PESTS BIO-GENE TECHNOLOGY LIMITED (AU) 2023-09-21 US disclosed
US-11712039-B2 Control of resistant pests BIO-GENE TECHNOLOGY LIMITED (AU) 2023-08-01 US disclosed
US-11259522-B2 Control of resistant pests BIO-GENE TECHNOLOGY LIMITED (AU) 2022-03-01 US disclosed
US-20210076675-A1 PEST MANAGEMENT BIO GENE TECH LIMITED (AU) 2021-03-18 US disclosed
US-20210051951-A1 CONTROL OF RESISTANT PESTS BIO-GENE TECHNOLOGY LIMITED (AU) 2021-02-25 US disclosed
US-20210051952-A1 METHODS FOR CONTROL OF PESTS BIO-GENE TECHNOLOGY LIMITED (AU) 2021-02-25 US disclosed
EP-3772951-A1 METHODS FOR CONTROL OF PESTS Bio-Gene Technology Limited (AU) 2021-02-17 EP disclosed
US-20040010009-A1 Benzamidine derivatives SANKYO COMPANY, LIMITED (JP) 2004-01-15 US disclosed
US-6555556-B1 N-(4-(1-acetimidoylpiperidin-4-yl)oxyphenyl)-N-((E)-3-(3 -amidinophenyl)-2-methyl-2-propenyl)sulfamoylacetic acid dihydrochloride for example; factor Xa inhibitors SANKYO COMPANY, LIMITED (JP) 2003-04-29 US disclosed
US-20030064970-A1 Compounds and therapies for the prevention of vascular and non-vascular pathologies NEORX CORPORATION 2003-04-03 US disclosed
EP-1245564-A1 BENZAMIDINE DERIVATIVES Sankyo Company, Limited (JP) 2002-10-02 EP disclosed
US-6410587-B1 FIBROSIS; ALZHEIMER'S DISEASE; ANTIARTHRITIC AGENTS NEORX CORPORATION 2002-06-25 US disclosed
US-6117911-A ADMINISTRATION OF AT LEAST ONE THERAPEUTIC AGENT THAT ELEVATES THE LEVEL OF TGF-BETA IN SAID MAMMAL. NEORX CORPORATION (US) 2000-09-12 US disclosed
WO-1998046588-A2 COMPOUNDS AND THERAPIES FOR THE PREVENTION OF VASCULAR AND NON-VASCULAR PATHOLOGIES NEORX CORPORATION (US) 1998-10-22 WO disclosed
US-5599848-A CONTROLLING CODLING MOTH BY INTERFERING MATING BASF AKTIENGESELLSCHAFT (DE) 1997-02-04 US disclosed
CN-1096032-A New active compound ASTRA AB (SE) 1994-12-07 CN disclosed
US-4016160-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1977-04-05 US disclosed